Galderma Group AG (SWX:GALD)
Switzerland
· Delayed Price · Currency is CHF 155.90
-0.10 (-0.06%)
At close: Mar 9, 2026
Galderma Group AG Revenue
In the year 2025, Galderma Group AG had annual revenue of $5.24B USD with 18.04% growth. Galderma Group AG had revenue of $2.78B in the half year ending December 31, 2025, with 32.02% growth.
Revenue
$5.24B
Revenue Growth
+18.04%
P/S Ratio
8.80
Revenue / Employee
$682.78K
Employees
7,676
Market Cap
36.57B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.24B | 801.00M | 18.04% |
| Dec 31, 2024 | 4.44B | 323.00M | 7.85% |
| Dec 31, 2023 | 4.12B | 293.10M | 7.66% |
| Dec 31, 2022 | 3.82B | 378.90M | 11.00% |
| Dec 31, 2021 | 3.45B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Lonza Group AG | 6.53B |
| Alcon | 8.25B |
| Sandoz Group AG | 8.85B |
| Straumann Holding AG | 2.61B |
| Sonova Holding AG | 3.85B |
| Galenica AG | 4.03B |
Galderma Group AG News
- 4 days ago - Galderma Group AG (GDERF) Full Year 2025 Earnings Call Highlights: Record Sales and Strategic ... - GuruFocus